| 中文名称 | 尿苷-5'-二磷酸钠盐 |
| 英文名称 | URIDINE 5'-DIPHOSPHORIC ACID SODIUM SALT |
| CAS号 | 21931-53-3 |
| 分子式 | C9H12N2Na2O12P2 |
| 分子量 | 448.12 |
| EINECS号 | 999-999-2 |
| 溶解度 | 在水中的溶解度为100mg/mL,透明,无色至微黄色 |
| 形态 | 粉末 |
| 颜色 | 白色 |
| 水溶解性 | Soluble in water to 100mM |
| 稳定性 | 吸湿性 |
| 危险品标志 | Xn |
| 危险类别码 | 22-68/22-68/20/21/22-20/21/22 |
| 安全说明 | 36/37 |
| WGK Germany | 3 |
| 海关编码 | 29349990 |
|
Human Endogenous Metabolite
|
Uridine 5'-diphosphate sodium salt (100 μM; for 15 min) significantly induces microglial CCL2 and CCL3 mRNA expression.
Uridine 5'-diphosphate sodium salt (100 μM; 3 hours) induces chemokine expression in microglia.
Uridine 5'-diphosphate sodium salt (100 μM; 0.5, 1, 3, 6 12 hours) induces expression of mRNA encoding CCL2 and CCL3 within 30 min, and such expression reaches maximal levels at 1 h, returning to basal levels at 3-12 h.
UDP (10, 100, 1000 μM; 3 hours) induces a concentration-dependent increase in the expression of chemokines at both the mRNA and protein level.
Uridine 5'-diphosphate sodium salt (100 μM; for 15 min) induces activation of NFATc1 and NFATc2 in microglia.
RT-PCR
| Cell Line: | Primary microglia |
| Concentration: | 100 μM |
| Incubation Time: | For 15 min |
| Result: | Significantly induced microglial CCL2 and CCL3 mRNA expression. |